Cagrilintide: what it is, how it is sold and how to track it

Updated 2026-10-15 · The Pep Planner

Cagrilintide often comes up next to GLP-1s, but it works on a different hormone system. This page covers what it is, where it stands and how to keep accurate records.

Educational overview for record keeping. Not medical advice, and no doses. Check the rules where you live.

What it is

Cagrilintide is a long-acting analog of amylin, a peptide hormone released by the pancreas alongside insulin. It acts on amylin receptors, not GLP-1 receptors.

It has been studied on its own and in combination with semaglutide, which is why the two names often appear together.

How it is usually sold

Research vials: freeze-dried powder labeled by milligrams per vial
Sometimes listed next to semaglutide; a single vial with both is a blend and should list both amounts

Regulatory status

Cagrilintide is investigational and not approved as a medicine in the U.S. Vials sold "for research use only" are not approved for human use.

Storage basics

Sealed vials are usually kept cold and away from light. Mixed vials are typically refrigerated and used within a window you set from the vendor's guidance.

How The Pep Planner helps you track it

Add cagrilintide as its own stockpile item with strength, vendor and lot. If you track it alongside another compound, keep them as separate items unless they truly come in one vial, so each count stays accurate.

Common questions

Is cagrilintide a GLP-1?

No. It is an amylin analog. It is grouped with GLP-1s in conversation because the two have been studied together.

Does this page recommend an amount?

No. The Pep Planner is an organizer and tracker. We do not give dosing or medical advice.

Try The Pep Planner free: 14-day trial, no card needed.